U-Blot® Research Grade vedastotugCat. No. WA3760Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade vedastotugCat. No. WA3760
U-Blot® Research Grade vecantoxatugCat. No. WA3759
U-Blot® Research Grade Vatreptacog alfaCat. No. WA3758
U-Blot® Research Grade VatelizumabCat. No. WA3757
U-Blot® Research Grade vasigrobartCat. No. WA3756
U-Blot® Research Grade varzutamigCat. No. WA3755
U-Blot® Research Grade varsetatugCat. No. WA3754
U-Blot® Research Grade VarokibartCat. No. WA3753
U-Blot® Research Grade VarlilumabCat. No. WA3752
U-Blot® Research Grade VarisacumabCat. No. WA3751
U-Blot® Research Grade VapaliximabCat. No. WA3750
U-Blot® Research Grade VanucizumabCat. No. WA3749